6 Cedarbrook Drive, Cranbury, NJ 08512, USA cfpc.jstar@jstar-research.com

 

Pharma Crystallization Summit

 

October 13-14, 2022, Princeton, New Jersey

 

Date Time Event Themes/Topics
Oct 13 6:00 - 8:00 Breakfast & Registration
8:00 - 12:00 Topical Workshop CMC Development Strategies
  • Combined In-Silico & Experimental Approach for Solid Form Screen & Selection
  • Enabling Technologies for Tox/FIH Formulation
  • Simulation Aided Process/Product Development, Scale-up, Tech-Transfer, and Regulatory Submission
  • 12:00 - 13:00 Lunch & Break
    13:00 - 17:00 Keynote Presentation Session 1: Smarter Solid Form & Pre-Formulation Studie
    Session 2: Physical Property Based Crystallization Process Dev
    17:00 - 21:00 Cocktail Social Hour & Gata Dinner
    Oct 14
    6:00 - 8:00 Breakfast
    8:00 - 12:00 Keynote Presentation Session 2: Physical Property Based Crystallization Process Dev
    Session 3: Particle Engineering & DS-DP Co-Processing
    12:00 - 13:00 Lunch & Break
    13:00 - 15:00 Pannel Discussion
  • Challenges and solutions of developing amorphous solids as drug substance
  • Bottlenecks and breakthroughs of computational solutions for drug substance & product development
  • Early formulation challenges and solutions – Discovery to Phase I
  • 15:00 - 15:30 Coffee/Tea Break & Shuttle to DS-DP Labs
    15:30 - 17:00 Lab Tour/ Demos Material Science | Process Dev. | PAT Application | Particle Engineering
    | Pre-Formulation | Formulation | R&D to GMP Delivery

    Program

    Programm

    Programm

    Meet 2021 PCS Speakers

    We Provide Best Service For Your Business

    About

    The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia. PCS programs are designed to stimulate in-depth discussions on common and/or leading bottleneck issues related to crystallization of drug substance (DS) as well as the intermediates, the technologies and solutions that are available or underdevelopment. The discussions help new medicine developers to make educated and phase-appropriate decisions, and crystallization experts to understand better the critical needs for providing effective solutions.

    Read More

    24

    Past Keynote Presentations

    591

    Past Attendees

    83

    % for Interesting Topics

    62

    % for Knowledge

    38

    Countries
    RSS
    Follow by Email
    LinkedIn
    Share